Market Overview:
The global anti-infective drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing incidence of infectious diseases, rising demand for novel anti-infective drugs, and growing awareness about hygiene and preventive measures against infections. The global anti-infective drugs market is segmented on the basis of type into over-the-counter (OTC) and prescription drugs. The OTC segment is expected to account for a larger share of the global market in terms of revenue due to the high demand for these drugs from consumers across all regions. On the basis of application, hospitals are expected to account for a larger share of the global market than drug stores owing to increased spending by healthcare institutions on infection control measures.
Product Definition:
An anti-infective drug is a type of medication that is used to treat infections caused by bacteria, viruses, or fungi. These drugs are important because they can help to clear up an infection and improve the patient's health.
OTC:
OTC stands for Over-the-Counter. It is a category of pharmaceutical drugs that are sold without a prescription and are used as medicines for the treatment of minor ailments like common cold, cough, skin infections, etc.
Rx Drugs:
Rx drugs are the ones that we buy from pharmacies to treat a particular disease or condition. The anti-infective drugs market is used for curing infections like malaria, HIV aids, hepatitis C and other diseases caused by viruses.
The global anti-infective drug market was valued at USD barium in 2015 and is expected to grow at a CAGR of XX% during the forecast period.
Application Insights:
The other application segment held the largest share of the global anti-infective drugs market in 2017. This is attributed to growing awareness about diseases and a rise in their treatment, especially among the geriatric population. Moreover, increasing government initiatives to control healthcare spending are also expected to have a positive impact on demand for anti-infective drugs over the forecast period.
Drug store is projected to be fastest growing application segment from 2018 to 2030 owing to rising purchasing power and high disposable income among certain groups of people, especially in developing countries like India and China. The availability of various payment options such as e-wallet enables consumers buy OTC medicines without going into debt or getting into financial difficulties due to high cost associated with it. These factors are likely drive growth of this segment over the forecast period (18).
On average, hospital costs between USD 10.
Regional Analysis:
North America dominated the global market in 2017. The presence of key anti-infective drug manufacturers, such as Pfizer Inc.; Gilead Sciences, Inc.; and Merck & Co., Inc., has fueled the growth of this regional market. Moreover, increasing prevalence of infectious diseases is also one of the major factors contributing to its growth. According to a study published by Centers for Disease Control and Prevention (CDC) in 2016; antibiotic-resistant bacteria are growing rapidly among Enterobacteriaceae that cause infections in adults as well as children throughout U.S. These factors have resulted into high demand for OTC drugs used against infectious diseases such as syphilis, gonorrhea, chlamydia etc.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the anti-infective drugs market. According to the World Health Organization (WHO), every year around 1.7 million people die from infections, and this number is estimated to rise in future due to the increase in global population and travel. This will create a high demand for anti-infective drugs, thereby driving the market growth.
- Rising prevalence of antibiotic resistance: The rising prevalence of antibiotic resistance is another major factor that is expected to drive the growth of anti-infective drugs market in future. Antibiotic resistance occurs when bacteria develop immunity against antibiotics, making it difficult or impossible to treat infections with these drugs. This growing problem has created a high demand for new and innovative antibiotics, which will help boost the growth of anti-infective drugs market over next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Anti-Infective Drugs Market Research Report
By Type
OTC, Rx Drugs
By Application
Hospital, Drugs Store, Other
By Companies
GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences, Abbott, Wyeth, Sanofi-Aventis, Bristol-Myers Squibb, Johnson, GlaxoSmithKline, Nanosphere, NanoViricides, Novabay Pharmaceuticals, Obetech, Optimer Pharmaceuticals, Basilea Pharmaceutica AG, Daiichi Sankyo, MerLion Pharma, Theravance
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Anti-Infective Drugs Market Report Segments:
The global Anti-Infective Drugs market is segmented on the basis of:
Types
OTC, Rx Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Store, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Merck
- Pfizer
- Novartis AG
- Gilead Sciences
- Abbott
- Wyeth
- Sanofi-Aventis
- Bristol-Myers Squibb
- Johnson
- GlaxoSmithKline
- Nanosphere
- NanoViricides
- Novabay Pharmaceuticals
- Obetech
- Optimer Pharmaceuticals
- Basilea Pharmaceutica AG
- Daiichi Sankyo
- MerLion Pharma
- Theravance
Highlights of The Anti-Infective Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- OTC
- Rx Drugs
- By Application:
- Hospital
- Drugs Store
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anti-Infective Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anti-infective drugs are medications used to treat infections. They work by killing or preventing the growth of bacteria, viruses, or fungi.
Some of the key players operating in the anti-infective drugs market are GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences, Abbott, Wyeth, Sanofi-Aventis, Bristol-Myers Squibb, Johnson, GlaxoSmithKline, Nanosphere, NanoViricides, Novabay Pharmaceuticals, Obetech, Optimer Pharmaceuticals, Basilea Pharmaceutica AG, Daiichi Sankyo, MerLion Pharma, Theravance.
The anti-infective drugs market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anti-Infective Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anti-Infective Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anti-Infective Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anti-Infective Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anti-Infective Drugs Market Size & Forecast, 2020-2028
4.5.1 Anti-Infective Drugs Market Size and Y-o-Y Growth
4.5.2 Anti-Infective Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 OTC
5.2.2 Rx Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Store
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anti-Infective Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anti-Infective Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 OTC
9.6.2 Rx Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Store
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 OTC
10.6.2 Rx Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Store
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 OTC
11.6.2 Rx Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Store
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 OTC
12.6.2 Rx Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Store
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 OTC
13.6.2 Rx Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Store
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anti-Infective Drugs Market: Competitive Dashboard
14.2 Global Anti-Infective Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Merck
14.3.3 Pfizer
14.3.4 Novartis AG
14.3.5 Gilead Sciences
14.3.6 Abbott
14.3.7 Wyeth
14.3.8 Sanofi-Aventis
14.3.9 Bristol-Myers Squibb
14.3.10 Johnson
14.3.11 GlaxoSmithKline
14.3.12 Nanosphere
14.3.13 NanoViricides
14.3.14 Novabay Pharmaceuticals
14.3.15 Obetech
14.3.16 Optimer Pharmaceuticals
14.3.17 Basilea Pharmaceutica AG
14.3.18 Daiichi Sankyo
14.3.19 MerLion Pharma
14.3.20 Theravance
